Hannover, Germany

Thomas Thum

USPTO Granted Patents = 17 

 

 

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 61(Granted Patents)


Location History:

  • Wuerzburg, DE (2014)
  • Hannover, DE (2003 - 2022)

Company Filing History:


Years Active: 2003-2022

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: The Innovations of Thomas Thum: Transforming Therapeutic Approaches in Hannover

Introduction: Thomas Thum, a prominent inventor based in Hannover, Germany, has made significant contributions to the field of medical science through his extensive work on long non-coding RNAs (lncRNAs). With a remarkable portfolio of 17 patents, his innovative approaches are paving new pathways in therapy and diagnostics.

Latest Patents: Among his latest inventions, Thum has developed two noteworthy patent applications. The first is titled "IncRNAS for therapy and diagnosis of angiogenesis," which encompasses pharmaceutical compositions designed to either promote or inhibit the expression of specific lncRNAs. This invention focuses on utilizing lncRNAs selected from distinct sequences, aiming to enhance therapeutic options for conditions related to angiogenesis.

The second patent, "LncRNAs for therapy and diagnosis of cardiac hypertrophy," centers on similar themes. This patent presents innovative pharmaceutical compositions that target lncRNAs to either promote or inhibit their activity, with the potential to treat or prevent cardiac hypertrophy. These advancements could lead to groundbreaking therapies for heart-related conditions.

Career Highlights: Thomas Thum has an esteemed career that includes significant roles at prestigious institutions such as Medizinische Hochschule Hannover and Julius Maximilians University of Würzburg. His work is characterized by a commitment to research and innovation in the medical field, particularly focusing on molecular therapies.

Collaborations: Throughout his career, Thum has collaborated with notable professionals in the industry, including Johann Bauersachs and Stefan Engelhardt. These partnerships have helped enhance his research efforts and have played a crucial role in advancing the science of lncRNAs.

Conclusion: Thomas Thum stands out as an influential inventor in the realm of medical innovations. His groundbreaking patents highlight the potential of lncRNAs in therapeutic applications, promising new avenues for diagnosis and treatment. As he continues to push the boundaries of scientific discovery, Thum's contributions are sure to leave a lasting impact on the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…